![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Determinants of Variability in ISG15 Gene Expression in Patients With Chronic Hepatitis B (CHB) Infection During Treatment With Oral TLR-7 Agonist GS-9620
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Edward J. Gane,1 Stuart C. Gordon,2 Shyamasundaran Kottilil,3 Benedetta Massetto,4 Anuj Gaggar,4 Scott Stem,4 Stefan Pflanz,4 Zhishen Ye,4 G. Mani Subramanian,4 John G. McHutchison,4 Young-Suk Lim,5 Yoon Jun Kim6
1Auckland Clinical Studies, Auckland, New Zealand; 2Henry Ford Health Systems, Detroit, Michigan, USA; 3National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA; 4Gilead Sciences, Inc., Foster City, California, USA; 5Asan Medical Center, Seoul, South Korea; 6Seoul National University Hospital, Seoul, South Korea
![EASL1.gif](../images/042814/042814-1/EASL1.gif)
![EASL2.gif](../images/042814/042814-1/EASL2.gif)
![EASL3.gif](../images/042814/042814-1/EASL3.gif)
![EASL4.gif](../images/042814/042814-1/EASL4.gif)
![EASL5.gif](../images/042814/042814-1/EASL5.gif)
![EASL6.gif](../images/042814/042814-1/EASL6.gif)
![EASL7.gif](../images/042814/042814-1/EASL7.gif)
![EASL8.gif](../images/042814/042814-1/EASL8.gif)
![EASL9.gif](../images/042814/042814-1/EASL9.gif)
![EASL10.gif](../images/042814/042814-1/EASL10.gif)
![EASL11.gif](../images/042814/042814-1/EASL11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|